Gene · 3669
Papers4,236
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 4,236
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Type I interferon transcriptional network regulates expression of coinhibitory receptors in human T cells. | Nat Immunol | 2022 | 35301508 | PubTator, text mining | PubMed |
| Single-cell RNA-seq reveals clonal diversity and prognostic genes of relapsed multiple myeloma. | Clin Transl Med | 2022 | 35297204 | PubTator, text mining | PubMed |
| Identification and characterisation of spontaneous mutations causing deafness from a targeted knockout programme. | BMC Biol | 2022 | 35296311 | PubTator, text mining | PubMed |
| Mild COVID-19 imprints a long-term inflammatory eicosanoid- and chemokine memory in monocyte-derived macrophages. | Mucosal Immunol | 2022 | 35288643 | PubTator, text mining | PubMed |
| Analysis of the long non-coding RNA and mRNA expression profiles associated with lidocaine-induced neurotoxicity in the spinal cord of a rat model. | Neurotoxicology | 2022 | 35283115 | PubTator, text mining | PubMed |
| PRRX1 Is a Novel Prognostic Biomarker and Facilitates Tumor Progression Through Epithelial-Mesenchymal Transition in Uveal Melanoma. | Front Immunol | 2022 | 35281030 | PubTator, text mining | PubMed |
| Identification of key biomarkers and immune infiltration in renal interstitial fibrosis. | Ann Transl Med | 2022 | 35280428 | PubTator, text mining | PubMed |
| [Early onset Epstein-Barr virus-negative diffuse large B cell lymphoma after bilateral lung transplantation: a case report]. | Zhonghua Jie He He Hu Xi Za Zhi | 2022 | 35279993 | PubTator, text mining | PubMed |
| A pan-cancer analysis of the oncogenic role of Holliday junction recognition protein in human tumors. | Open Med (Wars) | 2022 | 35274047 | PubTator, text mining | PubMed |
| Lymphoplasmacytic Lymphoma with Only Lambda Light Chain Monoclonal Paraprotein Expression. | Eur J Case Rep Intern Med | 2022 | 35265542 | PubTator, text mining | PubMed |
| Increased Sensitivity of SARS-CoV-2 to Type III Interferon in Human Intestinal Epithelial Cells. | J Virol | 2022 | 35262371 | PubTator, text mining | PubMed |
| Transcriptomic Analysis of Papillary Thyroid Cancer: A Focus on Immune-Subtyping, Oncogenic Fusion, and Recurrence. | Clin Exp Otorhinolaryngol | 2022 | 35255661 | PubTator, text mining | PubMed |
| High Frequency of Post-Transfusion Microchimerism Among Multi-Transfused Beta-Thalassemic Patients. | Front Med (Lausanne) | 2022 | 35252277 | PubTator, text mining | PubMed |
| The long non-coding RNA LNC_000397 negatively regulates PRRSV replication through induction of interferon-stimulated genes. | Virol J | 2022 | 35248059 | PubTator, text mining | PubMed |
| Identification of the Hub Genes and the Signaling Pathways in Human iPSC-Cardiomyocytes Infected by SARS-CoV-2. | Biochem Genet | 2022 | 35235083 | PubTator, text mining | PubMed |
| Oncolytic Zika virus promotes intratumoral T cell infiltration and improves immunotherapy efficacy in glioblastoma. | Mol Ther Oncolytics | 2022 | 35229030 | PubTator, text mining | PubMed |
| Single-cell multi-omics analysis of human pancreatic islets reveals novel cellular states in type 1 diabetes. | Nat Metab | 2022 | 35228745 | PubTator, text mining | PubMed |
| Recent advances in the diagnosis of intestinal tuberculosis. | BMC Gastroenterol | 2022 | 35227196 | PubTator, text mining | PubMed |
| Synergistic Effects of Toll-Like Receptor 1/2 and Toll-Like Receptor 3 Signaling Triggering Interleukin 27 Gene Expression in Chikungunya Virus-Infected Macrophages. | Front Cell Dev Biol | 2022 | 35223841 | PubTator, text mining | PubMed |
| AKT Hyperphosphorylation and T Cell Exhaustion in Down Syndrome. | Front Immunol | 2022 | 35222360 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3669/papers?page=53